Cardiovascular events in patients with fabry disease natural history data from the fabry registry.
about
Analysis of left ventricular mass in untreated men and in men treated with agalsidase-β: data from the Fabry Registry.Time to treatment benefit for adult patients with Fabry disease receiving agalsidase β: data from the Fabry Registry.Arrhythmias in Fabry cardiomyopathy.Effectiveness of enzyme replacement therapy in Fabry disease: Long term experience in Argentina.Amiloride as an Alternate Adjuvant Antiproteinuric Agent in Fabry Disease: The Potential Roles of Plasmin and uPAR.PET-CMR in heart failure - synergistic or redundant imaging?Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study.Lipid profile in adult patients with Fabry disease - Ten-year follow upLong-term outcome of enzyme-replacement therapy in advanced Fabry disease: evidence for disease progression towards serious complicationsA disproportionate contribution of papillary muscles and trabeculations to total left ventricular mass makes choice of cardiovascular magnetic resonance analysis technique critical in Fabry diseaseEnzyme replacement therapy for Anderson-Fabry disease: A complementary overview of a Cochrane publication through a linear regression and a pooled analysis of proportions from cohort studies.Long term enzyme replacement therapy for Fabry disease: effectiveness on kidney, heart and brain.Early cardiac changes in children with anderson-fabry disease.Gender Differences in the Application of Spanish Criteria for Initiation of Enzyme Replacement Therapy for Fabry Disease in the Fabry Outcome Survey.Natural course of Fabry disease and the effectiveness of enzyme replacement therapy: a systematic review and meta-analysis: effectiveness of ERT in different disease stages.Cardiac involvement in genotype-positive Fabry disease patients assessed by cardiovascular MR.Stroke and Hypertension in Children and Adolescents.The value of ECG parameters as markers of treatment response in Fabry cardiomyopathy.Fabry disease in Argentina: an evaluation of patients enrolled in the Fabry Registry.Relationship between left ventricular diastolic function and myocardial sympathetic denervation measured by (123)I-meta-iodobenzylguanidine imaging in Anderson-Fabry disease.Loss of base-to-apex circumferential strain gradient: A specific pattern of Fabry cardiomyopathy?Phenotypic characteristics of the p.Asn215Ser (p.N215S) GLA mutation in male and female patients with Fabry disease: A multicenter Fabry Registry study.A pilot study of circulating microRNAs as potential biomarkers of Fabry disease.Cardiac Phenotype of Prehypertrophic Fabry Disease.Anderson-Fabry disease in heart failure
P2860
Q30632134-91A4742D-99BE-49F8-B1B8-FF807BBC1CC0Q31060724-0F057935-1BA0-4F0C-BEAA-442B3D8AB11CQ33161649-A5542CAC-406A-49F0-BF3B-50FCAB4F99E4Q33652370-4E0F87EB-4686-4FCC-B46F-5AF842D332DEQ33737225-4565C769-E692-4EFE-B190-9EBA1020AF70Q33844251-71CD76F8-2514-461A-9AAB-8FBC9B591A92Q33886219-5A8503D1-F059-47CD-BBEF-4F579771FFA0Q33904518-F2407556-36DF-4DF8-83BD-E6AEE4D222EFQ34805283-ED902DA8-4CBF-4F54-AE3A-0964CE33104CQ35104405-E603988B-4575-4F1C-8415-7B597C6799DAQ36309032-776CE6F2-B20C-4B67-9D91-ED9FB93D6BD7Q36767452-42BDD505-2889-4D95-87BA-8F0CCB05D625Q37127636-FAAFC6CF-1405-4041-8B14-A15CC9F17D68Q37534497-475BE53C-B9EB-4EFD-B3C7-CBB272745855Q38184922-072481B0-7C33-4F48-A153-3D0AF7A499D4Q38418582-5DF2A4F4-0F70-416A-B16F-DE2608BB130BQ39055426-B5E1BAEB-E8EF-495C-AFBE-CB42F37D32BBQ43628771-D1CA9062-E8C6-42D0-AF07-4CF66AC1BA25Q44063760-8E2271F2-A932-4828-872B-AA06C1B36771Q48093590-CCBC5AB3-2881-4DA1-A580-3975EF95D4A5Q48168782-4C2A0BC7-F95F-41D1-8A41-6F72A84D2B62Q54236852-A194A9E1-D28F-4966-A071-7055543563A7Q55361498-17760331-9646-4A28-BD12-47E1D657C405Q55689337-B43647BC-2DDB-46A5-82E9-8B799A69C013Q56807662-E30CFF52-2BC1-44B8-ABAD-C8E081F42E73
P2860
Cardiovascular events in patients with fabry disease natural history data from the fabry registry.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Cardiovascular events in patie ...... data from the fabry registry.
@ast
Cardiovascular events in patie ...... data from the fabry registry.
@en
type
label
Cardiovascular events in patie ...... data from the fabry registry.
@ast
Cardiovascular events in patie ...... data from the fabry registry.
@en
prefLabel
Cardiovascular events in patie ...... data from the fabry registry.
@ast
Cardiovascular events in patie ...... data from the fabry registry.
@en
P2093
P50
P1476
Cardiovascular events in patie ...... data from the fabry registry.
@en
P2093
Ademola Abiose
Dana Beitner-Johnson
Ilkka Kantola
Jose Tallaj
Jörg Strotmann
Manesh R Patel
Marta Cizmarik
Michael L West
Thi Chien Tran
P304
P356
10.1016/J.JACC.2010.11.018
P407
P577
2011-03-01T00:00:00Z